COVID-19 in India: Bharat Biotech's 'Covaxin' Gets Emergency Use Authorisation for Children Between 6-12 Years
The Drugs Controller General of India (DCGI) has given restricted emergency use authorisation to Bharat Biotech's 'Covaxin'.
Amid the ongoing surge in COVID-19 cases across the country, the Drugs Controller General of India (DCGI) has given restricted emergency use authorisation to Bharat Biotech's 'Covaxin' for children between the age of 6-12 years, report sources.
Check tweet:
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)